title: Symptomatic intracerebral and systemic hemorrhage after stroke thrombolysis in patients taking ticagrelor.
authors.affiliation: Department of Neurology, Royal Melbourne Hospital, Parkville, Australia.
authors.forename: Kar Yan
authors.initials: KY
authors.lastname: Lo
authors.affiliation: Stroke Center, The Moses H. Cone Memorial Hospital, Greensboro, NC, USA.
authors.forename: Sharon
authors.initials: S
authors.lastname: Biby
authors.affiliation: Stroke Center, The Moses H. Cone Memorial Hospital, Greensboro, NC, USA.
authors.forename: Pramod
authors.initials: P
authors.lastname: Sethi
authors.affiliation: Department of Medicine, Royal Melbourne Hospital, Parkville, AustraliaDepartment of Neurology, Royal Melbourne Hospital, Parkville, AustraliaMelbourne Brain Centre, University of Melbourne, Melbourne, Australia Bruce.Campbell@mh.org.au.
authors.forename: Bruce Cv
authors.initials: BC
authors.lastname: Campbell
mesh_terms: D000241:Adenosine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000368:Aged; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006470:Hemorrhage / Q000209:etiology*; D006801:Humans; D020521:Stroke / Q000175:diagnosis / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D000077486:Ticagrelor; D010959:Tissue Plasminogen Activator / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator; D000077486:Ticagrelor; D000241:Adenosine